0001189724-16-000015.txt : 20160331
0001189724-16-000015.hdr.sgml : 20160331
20160331190333
ACCESSION NUMBER: 0001189724-16-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160331
DATE AS OF CHANGE: 20160331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Scott E
CENTRAL INDEX KEY: 0001375852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 161544531
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-03-31
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001375852
Lamb Scott E
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Secretary, Treasurer,
Common Stock
2016-03-31
4
X
0
15000.0
37.0
A
19381
D
Common Stock
2016-03-31
4
S
0
15000.0
105.0
D
4381
D
Common Stock
2016-03-31
4
X
0
15000.0
32.31
A
19381
D
Common Stock
2016-03-31
4
S
0
15000.0
105.0
D
4381
D
Common Stock
2016-03-31
4
X
0
14026.0
38.85
A
18407
D
Common Stock
2016-03-31
4
S
0
14026.0
105.0
D
4381
D
Non-Qualified Stock Option (right to buy)
32.31
2016-03-31
4
X
0
15000.0
32.31
D
2020-02-04
Common Stock
15000
0
D
Non-Qualified Stock Option (right to buy)
37.0
2016-03-31
4
X
0
15000.0
37.0
D
2020-07-21
Common Stock
15000
0
D
Non-Qualified Stock Option (right to buy)
38.85
2016-03-31
4
X
0
14026.0
38.85
D
2019-07-22
Common Stock
14026
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2015.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
Transaction is the exercise of a derivative security; see Column 2.
By: Paula Darbyshire For: Scott E. Lamb
2016-03-31